SmartGenomics NGS Solid Tumor + Heme – Test Update

This will take effect August 25, 2014

Overview and Clinical Utility:

PathGroup has made changes to both the solid tumor and hematomalignancy panels performed via Next-Generation Sequencing (NGS) as a part of SmartGenomics™ orders.

Click Here to read more.